Recently, crystal structure studies of the Casq2K180R maps the mutation to the filament-forming interface67, and it was proposed that disrupted Casq2 polymer formation may be responsible for Casq2 mutant-associated CPVT. Here, CASQ2 is linked to catecholaminergic polymorphic ventricular tachycardia.